Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
denosumab (prolia) (1 trial)
Histiocytosis (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2)
Trials (1 total)
Trial APIs (1 total)